Avid Bioservices Inc (CDMO)

[asmarterwookie]

The Yervoy Bavi was human trials.

Group A will enroll up to 16 patients to receive 2 weekly doses of bavituximab (3mg/kg) followed by combination therapy of ipilimumab (up to four cycles at 3mg/kg every 3 weeks) plus bavituximab (3mg/kg weekly for 12 weeks)

Group B will enroll up to 8 patients to receive standard ipilimumab alone (up to four cycles at 3mg/kg every 3 weeks)

Have not heard anything more about it have we?

The SOC changed during that time. Yes?

wook